Surgical Science Sweden AB

SUS · Nasdaq Stockholm · Healthcare

50.05SEK −2.2%last day

Price as of 2 October 2026

The price over the past year, with dividends: −43.1%

Performance

1 month

−3.4%

1 year

−43.1%

3 years, per year

−29.5%

5 years, per year

−26.6%

Largest fall, 3 years

−90.8%

Below the peak now

−84.6%

Volatility, 1 year

80.8%

Return with dividends reinvested.

Key figures

P/E

26.5

P/B

0.5

Dividend yield

0.0%

Return on equity

+2.0%

Net margin

+9.1%

Market value

254 m USD

Quality, value and trend

Where Surgical Science Sweden stands against every Nordic stock today. 100 is best.

Quality79

Profitability and a sound balance sheet over time. Better than 79% of Nordic stocks.

Value72

The price measured against earnings, assets and cash flow. Better than 72% of Nordic stocks.

Trend73

The price development over the past year. Better than 73% of Nordic stocks.

Combined92

Quality, value and trend together. Better than 92% of Nordic stocks.

About Surgical Science Sweden

Surgical Science Sweden AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 320 employees.

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexV…

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis